GLENMARK — Glenmark Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹628.43bn
- IN₹620.37bn
- IN₹169.83bn
Brief: Glenmark Pharma Says USA Unit To Launch Dextroamphetamine Saccharate Tablets
Indian pharma stocks decline after Trump again threatens tariffs (updated)
Indian pharma stocks decline after Trump again threatens tariffs
Brief: Glenmark Pharmaceuticals Inc., USA Launches Vancomycin Hydrochloride For Injection USP, 750 Mg/Vial, 1.25 G/Vial And 1.5 G/Vial (Single-Dose Vial)
India's Glenmark Pharma rises; HSBC upgrades to 'buy'
Brief: Glenmark Pharma- Receives FDA Approval For Olopatadine Hydrochloride Ophthalmic Solution
Brief: Glenmark Pharmaceuticals Says Glenmark Pharmaceuticals Inc Launches Epinephrine Injection Usp Multiple-Dose Vial
India Stocks: Indian shares slide as US growth concerns, foreign sell-off weigh
India's Glenmark Pharma rises on settling anti-trust lawsuit with plaintiffs
Factbox: Indian drugmakers with big US exposure as Trump plans pharmaceutical import tariffs
India's Glenmark Pharma misses profit estimates on weak North America sales
Brief: Glenmark Pharma Q3 Consol Net Profit 3.48 Billion Rupees
Brief: Glenmark Pharmaceuticals Receives MHRA Approval To Market Winlevi In UK
India's Torrent Pharma misses Q3 profit estimates, hurt by insulin plant closure
India's Mankind Pharma misses Q3 profit view as expenses jump
Brief: Glenmark Pharmaceuticals Launches Phytonadione Injectable Emulsion USP
Brief: Glenmark Pharma Says Glenmark Pharma Inc., USA Launches Lacosamide Oral Solution
India's Glenmark Pharma up on positive early-stage results for blood cancer drug
Brief: Glenmark Pharmaceuticals Says No Dose-Limiting Toxicities Observed In ISB 2001 Study